Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Orphenadrine measurement |
Component |
True |
Orphenadrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Orphenadrine adverse reaction |
Causative agent (attribute) |
True |
Orphenadrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Orphenadrine hydrochloride adverse reaction (disorder) |
Causative agent (attribute) |
False |
Orphenadrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Allergy to orphenadrine (finding) |
Causative agent (attribute) |
False |
Orphenadrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
allergie au chlorhydrate d'orphénadrine |
Causative agent (attribute) |
False |
Orphenadrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing orphenadrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Orphenadrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Acetaminophen+orphenadrine citrate 500mg/50mg caplets |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Orphenadrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Orphenadrine citrate |
Is a |
False |
Orphenadrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Orphenadrine hydrochloride (substance) |
Is a |
False |
Orphenadrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Orphenadrine citrate (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Orphenadrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Aspirin 385 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Orphenadrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Aspirin 428 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Orphenadrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely aspirin 770 milligram and caffeine 60 milligram and orphenadrine citrate 50 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Orphenadrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Aspirin 856 mg and caffeine 60 mg and orphenadrine citrate 50 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Orphenadrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Aspirin + caffeine + orphenadrine citrate tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Orphenadrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Acetaminophen + orphenadrine citrate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Orphenadrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Aspirin + caffeine + orphenadrine citrate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Orphenadrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing aspirin and caffeine and orphenadrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Orphenadrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Orphenadrine-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Orphenadrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing orphenadrine in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Orphenadrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely orphenadrine 50 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Orphenadrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Allergy to orphenadrine (finding) |
Causative agent (attribute) |
True |
Orphenadrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely orphenadrine 50 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Orphenadrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely orphenadrine 50 milligram/1 each conventional release oral tablet |
Has basis of strength substance (attribute) |
False |
Orphenadrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing orphenadrine and paracetamol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Orphenadrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Orphenadrine citrate |
Is modification of (attribute) |
True |
Orphenadrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Orphenadrine hydrochloride (substance) |
Is modification of (attribute) |
True |
Orphenadrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing aspirin and caffeine and orphenadrine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Orphenadrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely orphenadrine 50 milligram/1 each conventional release oral tablet |
Has precise active ingredient |
False |
Orphenadrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only aspirin and caffeine and orphenadrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Orphenadrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Orphenadrine and paracetamol only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Orphenadrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Orphenadrine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Orphenadrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only aspirin and caffeine and orphenadrine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Orphenadrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only orphenadrine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Orphenadrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only orphenadrine in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Orphenadrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |